CD Biosynsis offers professional Synechococcus spp. Pathway Optimization Services, leveraging the photosynthetic power of these fast-growing cyanobacteria to create efficient sustainable production platforms. Synechococcus species, such as the freshwater S. elongatus PCC 7942 and the fast-growing marine Synechococcus sp. PCC 7002, are premier "chassis" for solar-driven chemical synthesis. However, native metabolic flux is often tightly regulated to prioritize survival and glycogen storage. Our services identify and remove these metabolic bottlenecks, redirecting carbon and light energy toward high-value molecules like 2,3-butanediol, squalene, sucrose, and biodegradable plastics (PHB).
Our optimization solutions utilize a rigorous Design-Build-Test-Learn cycle tailored to the unique physiology of cyanobacteria. By integrating Genome-Scale Metabolic Models (GEMs) with advanced CRISPR-mediated genome editing, we perform systems-level rewiring. We address the hurdles of polyploidy and metabolic cross-talk, ensuring that optimized pathways are stable across all chromosomal copies. Whether you are aiming to "humanize" protein production or maximize carbon sequestration efficiency, our platform provides the technical expertise and analytical verification necessary to deliver high-performance Synechococcus strains ready for industrial photobioreactors.
Get a QuoteOptimizing pathways in Synechococcus requires more than simple gene overexpression; it requires a balanced coordination between the Calvin cycle, central carbon metabolism, and the target biosynthetic route. Our platform utilizes Flux Balance Analysis (FBA) to simulate metabolic "leaks" and predict the impact of genetic modifications on growth and productivity. This allows us to prioritize targets that maximize the "Titer, Rate, and Yield" (TRY) of your target metabolite.
A critical component of our strategy is the management of the Carbon Concentrating Mechanism (CCM) and light utilization. We optimize the expression of carboxysome components and light-harvesting antennae to ensure that the "fuel" (carbon and energy) is supplied at a rate that matches the capacity of the optimized pathway. By utilizing validated "Neutral Sites" for pathway integration, we ensure that new biosynthetic routes do not disrupt essential circadian rhythms or native growth vigor, resulting in industrial strains that remain stable under the fluctuating conditions of large-scale cultivation.
We provide a diversified toolkit of strategies to achieve peak metabolic performance in Synechococcus strains.
Sink Removal
Utilizing CRISPR to knockout genes involved in glycogen (storage carbohydrate) or PHB synthesis to force carbon flux into target metabolic branches.
Precursor Supply
Upregulating enzymes at key nodes (e.g., pyruvate or acetyl-CoA) to increase the availability of building blocks for the target biosynthetic route.
Multi-Gene KI
Site-specific integration of exogenous multi-enzyme cassettes into validated Neutral Sites (NS1, NS2, NS3) for stable, coordinated expression.
Codon Optimization
Full gene synthesis using proprietary Synechococcus-specific codon bias matrices to maximize translational throughput and avoid mRNA instability.
Promoter Libraries
Utilizing a range of constitutive and inducible cyanobacterial promoters (e.g., Ptrc, PpsbAII, Prha) to fine-tune enzyme stoichiometry.
CRISPRi Balancing
Applying dCas9/dCas12a-mediated repression to "dim" essential but competing pathways, finding the optimal balance between biomass growth and bioproduct titer.
Our systematic workflow ensures every project is backed by predictive modeling and rigorous experimental validation.
1. In Silico Flux Modeling
2. Multi-Locus Genetic Build
3. Accelerated Segregation
4. Metabolic Validation
Establishing a baseline metabolic model (GEM) for the target strain. Identifying bottlenecks via FBA and designing CRISPR-based modifications (KO, KI, or Repression).
Construction of optimization cassettes. Transformation via natural competence, conjugation, or electroporation. Implementation of multi-gene rewiring across target loci.
Quantitative analysis using GC-MS, HPLC, and PAM fluorometry. Long-term stability testing (30+ passages) to ensure the optimized phenotype remains fixed. Delivery of verified strains and data.
Flux-Driven Precision
Strategies are informed by predictive metabolic modeling, focusing on targets with the highest impact on yield while maintaining growth.
Rapid Homozygosity
Our CRISPR selective pressure techniques reduce the time required for chromosomal segregation in polyploid Synechococcus by up to 70%.
Neutral Site Expertise
Integration into pre-validated Neutral Sites ensures that new pathways do not disrupt native physiology or circadian regulation.
Industrial Alignment
Strains are optimized for high-density growth and productivity in photobioreactor conditions, focusing on photosynthetic resilience.
1. How do you identify which enzymes to overexpress?
We utilize Flux Balance Analysis (FBA) to identify "rate-limiting" steps in your target pathway. This quantitative approach identifies where carbon flux is restricted, allowing for targeted enzyme tuning.
2. What is the advantage of Neutral Site (NS) integration?
NS loci are genomic regions where integration doesn't disrupt native functions. This ensures stable expression and prevents the metabolic instability often seen with random integration.
3. Can you optimize the production of non-native bioproducts?
Yes. We have successfully optimized pathways for various non-native molecules, including alcohols, sugars, and organic acids, by integrating exogenous biosynthetic pathways.
4. How is chromosomal segregation handled for large pathway inserts?
We use CRISPR selective pressure to actively eliminate wild-type chromosomal copies. This forces the cell to maintain the large pathway insert across all genome copies efficiently.
5. Do you provide help with selecting promoters and RBS?
Yes. We offer a library of validated cyanobacterial-specific regulatory parts to ensure each enzyme in the pathway is expressed at the stoichiometric level needed for maximal flux.
6. How do you verify the final production titer?
We perform quantitative analysis using GC-MS or HPLC on the optimized strains grown in photobioreactors to confirm that the bioproduct yields meet the target requirements.
7. Is the optimized strain stable across generations?
Absolutely. We conduct 30-50 passage stability trials and re-genotype the strains via NGS to ensure the genetic modifications and production performance are fixed.
8. What is the typical lead time for a pathway optimization project?
Due to the complexity of multi-gene engineering and metabolic validation, these projects typically range from 16 to 24 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.